Plasma extracellular vesicle messenger RNA profiling identifies prognostic EV signature for non-invasive risk stratification for survival prediction of patients with pancreatic ductal adenocarcinoma

Table 2 Primary antibodies used for western blot

No	Name	Company and catalog number	Dilution used
1	CD9	Abcam, ab92726	1:500
2	CD63	Abcam, ab68418	1:1000
3	Calreticulin	Cell Signaling Technology, #2891S	1:1000
4	Integrin-b1	Cell Signaling Technology, #9699	1:500
5	TSG101	Abcam, ab83	1:500
6	Ras^G12D	Cell Signaling Technology, #14429	1:1000

ISSN: 1756-8722